Similar articles

• Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.

  Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B. Lelakowski J, et al. Kardiol Pol. 2012;70(12):1264-75. Kardiol Pol. 2012. PMID: 23264245
• [Prevention of sudden cardiac death and implantable cardioverter defibrillators: Understanding the competitive risk!].

  Rischard J, Narayanan K, Garcia R, Marijon E. Rischard J, et al. Presse Med. 2019 Dec;48(12):1401-1405. doi: 10.1016/j.lpm.2019.09.010. Epub 2019 Nov 4. Presse Med. 2019. PMID: 31699540 Review. French.
• [Implantable cardioverter-defibrillator in the treatment of two patients with an increased risk of sudden cardiac death].

  van den Berg MP, van Tintelen JP, van Dessel PF, van Veldhuisen DJ. van den Berg MP, et al. Ned Tijdschr Geneeskd. 2004 Oct 23;148(43):2132-5. Ned Tijdschr Geneeskd. 2004. PMID: 15553359 Dutch.
• Indications for implantable cardioverter defibrillator (ICD) therapy.

  Hauer RN, Aliot E, Block M, Capucci A, Lüderitz B, Santini M, Vardas PE; Study Group on Guidelines on ICD of the Working Group on Arrythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. Hauer RN, et al. Europace. 2001 Jul;3(3):169-76. doi: 10.1053/eupc.2001.0179. Europace. 2001. PMID: 11467456 No abstract available.
• A comprehensive approach to management of ventricular arrhythmias.

  Kusumoto F. Kusumoto F. Cardiol Clin. 2008 Aug;26(3):481-96, vii. doi: 10.1016/j.ccl.2008.03.002. Cardiol Clin. 2008. PMID: 18538192 Review.